Patents by Inventor Keltouma Driouch

Keltouma Driouch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KINDLIN-1 AS A MARKER OF SENSITIVITY TO EGFR/RAS PATHWAY INHIBITORS
    Publication number: 20230184775
    Abstract: The present invention concerns an ex vivo method for selecting patient having cancer as eligible to EGFR/RAS pathway inhibitor therapy, an EGFR/RAS pathway inhibitor for use for treating cancer in a patient, and a method for prognosis cancer outcome or progression.
    Type: Application
    Filed: May 11, 2021
    Publication date: June 15, 2023
    Applicant: INSTITUT CURIE
    Inventors: Keltouma Driouch, Rosette Lidereau
  • METHOD FOR THE PROGNOSIS OF THE PROGRESSION OF CANCER
    Publication number: 20130224192
    Abstract: The present invention relates to methods for the prognosis of the progression of cancer in a patient, and more particularly methods for the prediction of the occurrence of metastasis in one or more tissue or organ of patients affected with a cancer, in particular with a breast cancer, a lung cancer or other primary cancer, said methods comprising the step of detecting a higher expression level of FERMT1 gene in a tumour sample compared to a control reference values. The invention further relates to inhibitors of FERMT1 expression and their uses in the treatment of cancer or metastasis.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 29, 2013
    Applicant: Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Rosette Lidereau, Keltouma Driouch, Soraya Sin, Florian Bonin
  • METHOD FOR PREDICTING THE OCCURRENCE OF METASTASIS IN BREAST CANCER PATIENTS
    Publication number: 20100113297
    Abstract: The present invention relates to the prognosis of the progression of breast cancer in a patient, and more particularly to the prediction of the occurrence of metastasis in one or more tissue or organ of patients affected with a breast cancer.
    Type: Application
    Filed: February 26, 2008
    Publication date: May 6, 2010
    Applicant: CENTRE RENE HUGUENIN
    Inventors: Rosette Lidereau, Keltouma Driouch, Thomas Landemaine